Evidence map›Paper›PMID 28114279›Full record

ArticleOncogene2017

The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca

M Gueguinou, D Crottès, A Chantôme, R Rapetti-Mauss, M Potier-Cartereau, L Clarysse, A Girault, Y Fourbon, P Jézéquel, C Guérin-Charbonnel and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 109 citations in OpenAlex.

  1. Predictive model for clear cell renal cell carcinoma: a novel model integrating sunitinib resistance and prognosis related genes and clinical factors.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. The Role of Sigmar1 in Autophagy Regulation and Disease Therapy.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Mitochondria-ER crosstalk via MAMS: Bridging cellular homeostasis and cancer progression.Apoptosis : an international journal on programmed cell death · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Dysregulation of Mitochondrial Function in Cancer Cells.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. International journal of molecular sciences · 2024
    Article
  18. Review
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 1 country.

M GueguinouInserm-University U1069 Nutrition, Croissance et Cancer, Tours, France.
D CrottèsUniversité Côte d'Azur, CNRS, Inserm, iBV, France.
A ChantômeInserm-University U1069 Nutrition, Croissance et Cancer, Tours, France.
R Rapetti-MaussUniversité Côte d'Azur, CNRS, Inserm, iBV, France.
M Potier-CartereauInserm-University U1069 Nutrition, Croissance et Cancer, Tours, France.
L ClarysseInserm-University U1069 Nutrition, Croissance et Cancer, Tours, France.
A GiraultInserm-University U1069 Nutrition, Croissance et Cancer, Tours, France.
Y FourbonInserm-University U1069 Nutrition, Croissance et Cancer, Tours, France.
P JézéquelUnité de Bioinfomique, Institut de Cancérologie de L'Ouest - René Gauducheau, Centre de Recherche en Cancérologie, UMR-INSERM 892, St Herblain, France.
C Guérin-CharbonnelUnité de Bioinfomique, Institut de Cancérologie de L'Ouest - René Gauducheau, Centre de Recherche en Cancérologie, UMR-INSERM 892, St Herblain, France.
G FromontInserm-University U1069 Nutrition, Croissance et Cancer, Tours, France.
P MartinUniversité Côte d'Azur, CNRS, Inserm, iBV, France.
B PellissierUniversité Côte d'Azur, CNRS, Inserm, iBV, France.
R SchiappaUnité d'Epidémiologie et Biostatistiques (UEB), Centre Antoine Lacassagne, Nice, France.
E ChamoreyUnité d'Epidémiologie et Biostatistiques (UEB), Centre Antoine Lacassagne, Nice, France.
O MignenDepartment of Pathology, Inserm U1078, Brest University Hospital, Brest, France.
A UguenDepartment of Pathology, Inserm U1078, Brest University Hospital, Brest, France.
F BorgeseUniversité Côte d'Azur, CNRS, Inserm, iBV, France.
C VandierInserm-University U1069 Nutrition, Croissance et Cancer, Tours, France.
O SorianiUniversité Côte d'Azur, CNRS, Inserm, iBV, France.
Inserm · FRCentre National de la Recherche Scientifique · FRUniversité Côte d'Azur · FRCentre Antoine Lacassagne · FRBretonneau Hospital · FRCentre Hospitalier Régional Universitaire de Brest · FRInstitut de Cancérologie de l'Ouest · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The remodeling of calcium homeostasis contributes to the cancer hallmarks and the molecular mechanisms involved in calcium channel regulation in tumors remain to be characterized. Here, we report that SigmaR1, a stress-activated chaperone, is required to increase calcium influx by triggering the coupling between SK3, a Ca

Indexed as

Calcium SignalingCell MovementBreast NeoplasmsCalciumCell Line, TumorColorectal NeoplasmsFemaleHumansMaleNeoplasm ProteinsORAI1 ProteinReceptors, sigmaSigma-1 ReceptorSmall-Conductance Calcium-Activated Potassium ChannelsCalciumKCNN3 protein, humanNeoplasm ProteinsORAI1 ProteinORAI1 protein, humanReceptors, sigmaSigma-1 ReceptorSmall-Conductance Calcium-Activated Potassium Channels

Identifiers

PMID28114279
OpenAlexW2582032325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.